Agreement among Canadian retina specialists in the determination of treatment eligibility for photodynamic therapy in age-related macular degeneration
- PMID: 18667952
- DOI: 10.1097/IAE.0b013e3181814470
Agreement among Canadian retina specialists in the determination of treatment eligibility for photodynamic therapy in age-related macular degeneration
Abstract
Objectives: To determine inter- and intraobserver agreement among Canadian retina specialists in their angiographic classification of choroidal neovascularization and their decision to treat with photodynamic therapy. Agreement was also determined between retina specialists and a Reading Center.
Methods: Forty retina specialists graded 24 cases of exudative age-related macular degeneration on two occasions separated by 6 months. Participants were asked to categorize the choroidal neovascularization and indicate if they would treat with photodynamic therapy. Agreement was determined for decision to treat and for interpretation of the fluorescein angiogram. Angiographic interpretation by participants was compared with that of the Reading Center.
Results: The kappas among the 40 participants for lesion categorization and treatment decision were 0.43 (95% confidence interval: 0.36-0.52) and 0.29 (95% confidence interval: 0.18-0.42), respectively. The kappa for intraobserver agreement was 0.57 (95% confidence interval: 0.50-0.64) for lesion categorization and 0.58 (95% confidence interval: 0.43-0.74) for treatment decision. The mean percent agreement with the Reading Center for lesion categorization was 65.4%.
Conclusions: There was moderate interobserver agreement for choroidal neovascularization categorization and poor agreement among Canadian retina specialists for decision to treat with photodynamic therapy. There was moderate intraobserver agreement for both treatment decision and lesion categorization. There was moderate agreement between observers and the Reading Center for angiographic choroidal neovascularization categorization.
Similar articles
-
Agreement among ophthalmologists in evaluating fluorescein angiograms in patients with neovascular age-related macular degeneration for photodynamic therapy eligibility (FLAP-study).Ophthalmology. 2003 Feb;110(2):400-5. doi: 10.1016/S0161-6420(02)01770-0. Ophthalmology. 2003. PMID: 12578787 Clinical Trial.
-
Variability among retina specialists in evaluating fluorescein angiograms of patients with neovascular age-related macular degeneration.Retina. 2007 Jul-Aug;27(6):798-803. doi: 10.1097/IAE.0b013e31802c50a3. Retina. 2007. PMID: 17621192
-
Reproducibility of gradings of retinal photographs in eyes with subfoveal choroidal neovascularization and age-related macular degeneration in the macular photocoagulation study.Ophthalmic Epidemiol. 2008 May-Jun;15(3):191-201. doi: 10.1080/09286580701772003. Ophthalmic Epidemiol. 2008. PMID: 18569815
-
[Electroretinography in the diagnosis and monitoring of treatment for neovascular age-related macular degeneration: Communication 2].Vestn Oftalmol. 2009 Jul-Aug;125(4):55-9. Vestn Oftalmol. 2009. PMID: 19824452 Review. Russian.
-
Review of retinal angiomatous proliferation or type 3 neovascularization.Retina. 2008 Mar;28(3):375-84. doi: 10.1097/IAE.0b013e3181619c55. Retina. 2008. PMID: 18327130 Review. No abstract available.
Cited by
-
The level and efficacy of lutein in patients with age-related macular degeneration: a comprehensive systematic review and meta-analysis.Ann Transl Med. 2022 Mar;10(6):299. doi: 10.21037/atm-22-173. Ann Transl Med. 2022. PMID: 35433928 Free PMC article.
-
A systematic approach to evaluate practice-based process- and outcome data applied to the treatment of neovascular age-related macular degeneration.BMC Ophthalmol. 2020 Jan 9;20(1):21. doi: 10.1186/s12886-020-1303-y. BMC Ophthalmol. 2020. PMID: 31918701 Free PMC article.
-
The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases.Molecules. 2017 Apr 20;22(4):610. doi: 10.3390/molecules22040610. Molecules. 2017. PMID: 28425969 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical